Giants' Golden Tate loses appeal of suspension for PEDs

  • Giants' Golden Tate loses appeal of suspension for PEDs

Giants' Golden Tate loses appeal of suspension for PEDs

The Giants bolstered their wide receiver corps this offseason by signing Golden Tate, but it appears NY will begin the year without the 31-year-old pass-catcher.

After appealing the suspension that was handed down to him earlier in the offseason, New York Giants wide receiver Golden Tate will now officially end up having to miss out on the first four games of the 2019 regular season, as the team announced that he lost his appeal to the league.

Tate will be eligible to return to the Giants on September 30, one day after the club's Week 4 game against the Washington Redskins. He said he meant to appeal it and felt his case had merit because he was using a fertility drug prescribed by a doctor.

Tate previously indicated that the positive test came from a prescribed fertility medication.

Quarterback Eli Manning praised Tate on Tuesday prior the announcement of his appeal being denied. His appeal was heard August 6 by an arbiter in NY. The exemptions include fertility issues since some fertility drugs are known to serve as masking agents.

Tate's absence will be a big loss for the Giants, who are already struggling with depth at the receiver position without Odell Beckham Jr.

Sterling Shepard broke his left thumb in the opening practice.

Rookie Darius Slayton, the fifth-round draft choice, returned to practice this week after missing nearly all of training camp with a hamstring injury.

Tate, who is entering his 10th National Football League season, has previously played for the Seahawks, Lions and Eagles. In the middle of the 2018 season, he was traded to the Philadelphia Eagles.